ENVALITH
株式会社コスモス薬品 logo

COSMOS Pharmaceutical Corporation

3349Prime MarketRetail Trade

株式会社コスモス薬品 logo
COSMOS Pharmaceutical Corporation3349

COSMOS Pharmaceutical Corporation (Single Segment: Drugstore Business)

Nationwide rollout of "small trade area-type mega drugstores" offering daily consumables at low prices

PeriodCurrentPreviousChange
Net Sales (Full Year)¥1,011,390 million
Operating Profit (Full Year)¥40,404 million
Gross Profit Margin (Full Year)21.1%19.5%
Number of Stores at Period End1,609 stores (end of May 2025) / 1,662 stores (end of February 2026)
Ordinary Profit to Total Assets Ratio (Full Year)8.6%

Business Details

Operates drugstores stocked with daily consumable goods such as Pharmaceuticals, Cosmetics, Sundries, and General Food. Adopts a high-density, small trade area-focused store opening strategy targeting a trade area population of approximately 10,000 people, centered on the "Everyday Low Price" policy and low-cost operations. Expands its store network across six regions—Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu—capturing consumers' thrift-oriented spending. Green Flash Co., Ltd. (a special subsidiary for employing persons with disabilities) handles comprehensive store maintenance operations.

Recent Overview

Cumulative Q3 FY2026 (ending May 2026) sales were ¥810,380 million, up 7.7% year on year, showing steady growth

For the nine-month cumulative period of the third quarter of FY2026 (ending May 2026) (June 1, 2025 to February 28, 2026), the company recorded net sales of ¥810,380 million (up 7.7% year on year), operating profit of ¥32,021 million (up 1.2% year on year), ordinary profit of ¥33,865 million (up 0.3% year on year), and quarterly net income attributable to owners of the parent of ¥22,748 million (up 1.8% year on year). During the period, 57 new stores were opened (14 in Kanto, 13 in Chubu, 11 in Kansai, 2 in Chugoku, 8 in Shikoku, 9 in Kyushu), and 4 stores were closed, bringing the total number of stores at period end to 1,662. General Food expanded to become the largest category, accounting for 63.0% of sales. The Kanto and Chubu regions drove high growth, exceeding 20% year on year. There is no change to the full-year earnings forecast (net sales of ¥1,057,000 million, operating profit of ¥40,500 million).

Key Products

product
Pharmaceuticals

Handles OTC drugs, drink formulations, oral care products, nursing care products, vitamins, health foods, diet foods, and dispensing pharmacy services. Full-year sales for FY2025 (ending May 2025) were ¥140,639 million (up 2.9% year on year), accounting for 13.9% of total sales.

product
General Food

Handles processed foods, daily delivery foods (bread, milk, tofu, natto, eggs, etc.), seasonings, confectionery, beverages, and alcohol. Full-year sales for FY2025 (ending May 2025) were ¥619,082 million (up 6.2% year on year), accounting for 61.2% of total sales. This is the core category of the business model, which simultaneously pursues visit frequency and number of items purchased.

product
Sundries

Handles baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking utensils, gardening supplies, car supplies, and clothing. Full-year sales for FY2025 (ending May 2025) were ¥150,996 million (up 1.5% year on year), accounting for 14.9% of total sales.

product
Cosmetics

Handles cosmetics, men's cosmetics, hair care products, and bath additives. Full-year sales for FY2025 (ending May 2025) were ¥93,107 million (up 3.8% year on year), accounting for 9.2% of total sales. Provides "light counseling" by staff with specialized knowledge in Pharmaceuticals and Cosmetics.

service
Dispensing Pharmacy Business

Leverages high customer traffic to offer dispensing pharmacy services. Based on the outlook that drugstores will become the leading players in the dispensing pharmacy market, the company has explicitly stated market share expansion as a management strategy. Recorded as part of the Pharmaceuticals category.

Growth Drivers

  • Aggressive new store opening strategy: 120 new stores opened in FY2025 (ending May 2025), with expansion into new trade areas in the Kanto and Chubu regions driving high growth
  • Capturing consumers' thrift-oriented spending through the "Everyday Low Price" policy
  • Improvement in gross profit margin: achieved 21.1%, up 1.6 percentage points year on year, through procurement cost reduction negotiations and price pass-through amid inflation
  • Expansion of the General Food category: accounting for 61.2% of sales composition (up 6.2% year on year for the same quarter), contributing to increased visit frequency and number of items purchased
  • Small trade area-type high-density store opening model: continuous multi-store expansion enabled by an abundance of candidate store locations targeting a trade area population of approximately 10,000 people

Risks

  • Self-competition risk: the aggressive new store opening policy tolerates temporary declines in profitability, and the impact on existing stores from increased store density continues
  • Cost increase risk: rising costs such as labor and utility expenses due to inflation are pushing up selling, general and administrative expenses (up 10.3% year on year)
  • Consumption environment risk: declining consumer purchasing power due to price increases in goods and services stemming from domestic and international political instability and yen depreciation
  • Intensifying competition risk: progressing oligopolization in the drugstore industry due to mass store openings, mergers, and alliances among leading companies
  • Talent acquisition risk: securing and developing store operation management personnel amid accelerating multi-store expansion is explicitly stated as a management challenge

Last updated: August 28, 2025